Drug profile · INN
glasdegib
DAURISMO
glasdegib (DAURISMO) is a smoothened homolog antagonist.
EMA: approved Antineoplastic and immunomodulating agents (L01) L01XX63
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — glasdegib
- Class
- Antineoplastic and immunomodulating agents (L01)
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.83
Quick answer
glasdegib (DAURISMO) is a smoothened homolog antagonist.
Key facts
INN glasdegib
Brand DAURISMO
Mechanism Smoothened homolog antagonist
Target Protein smoothened
Therapeutic class Antineoplastic and immunomodulating agents (L01)
ATC code L01XX63
Mechanism of action
Smoothened homolog antagonist
Primary target: Protein smoothened
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is glasdegib?
glasdegib (DAURISMO) is a smoothened homolog antagonist.
What is the brand name for glasdegib?
DAURISMO is a marketed brand name for glasdegib. Check FDA Drugs@FDA for the current US label holder and prescribing information.